Gilead loses its challenge to a pair of U.S. patents for an HIV prevention pill
RICH PEDRONCELLI/AP
“This reinforces the position that the CDC patents are fully valid and enforceable," said James Krellenstein, a member of the PrEP4All Collaboration.
Suscribirse a:
Enviar comentarios (Atom)
.png)
No hay comentarios:
Publicar un comentario